picture of Quay Pharma has MHRA approval for the manufacture of commercial batches of drugs at its sites in Deeside (pictured) and Bromborough

Quay Pharma gains Commercial Licence to broaden its contract manufacturing services at its UK facilities

The expanded capabilities will allow the firm to support its clients through all stages of drug development and clinical supply

Recommended

Subscribers

Sign in now to see personalised content appear here.

You can also see your reading history and subscription details on your subscriber page.

Why subscribe?
Find out more.

Sign up for your FREE email newsletter  +

New

Servier appoints MaSTherCell to develop its cell therapy manufacturing platform

January 20, 2017

MaSTherCell is developing CAR-T cell therapy manufacturing platform, enabling industrial manufa ...

Europe | Manufacturing and Equipment

Cytovation appoint Ole-Erik Iversen as Scientific Advisor

January 20, 2017

Biotech company Cytovation has announced the appointment of Professor Ole-Erik Iversen as Scien ...

Europe | Infections

Using electrons to inactivate viruses in vaccines

January 4, 2017

Four institutes associated with the Fraunhofer Gesellschaft in Germany have been investigating ...

Europe | Vaccines | Cleaning

French Ethypharm acquires Martindale Pharma

January 19, 2017

Independent pharmaceutical company Ethypharm reinforces its UK presence by acquiring Martindale ...

Europe | Drug Delivery | Finance

Sartorius combines GAMP 4 software with benchtop bioreactor system

January 19, 2017

New technology enables design space characterisation for enhanced, large-scale process analytic ...

Europe | R and D | Manufacturing and Equipment | Information Technology

UK outsourcing: opportunities for British manufacturers in a post-Brexit world

December 19, 2016

The world of outsourcing in the pharmaceutical and health technology sector is at a crossroads. ...

Europe | Manufacturing and Equipment

Merck opens production facility exclusively for meglumine

January 18, 2017

The facility in Spain produces only the FDA-approved excipient meglumine, ensuring continuous s ...

Ingredients | Europe | Manufacturing and Equipment

Understanding the real risks of packaging

December 7, 2016

When it comes to GMP production, specifying the type of packaging to be taken into the cleanroo ...

Packaging | Europe

Handling potent APIS with care and confidence

October 5, 2016

Potent active pharma ingredients require ultra careful handling and containment. ChargePoint hi ...

Containment | Europe | Manufacturing and Equipment

Flexible Compact Isolators for precision manufacturing

January 17, 2017

The Hosokawa Flexible Compact Isolator allows for greater contamination control with its small ...

Containment | Europe | Manufacturing and Equipment

Pharma industry says EDC criteria need a risk-based approach

September 29, 2016

Strict, science-based guidelines will be implemented as soon as possible

Ingredients | Europe | Regulatory

In Brief